US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist

14.100
-0.260-1.81%

Trading May 10 11:23 ET

476.00MMarket Cap20.43P/E (TTM)

Entrada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-112.55%-25.52M

249.07%139.8M

85.30%-4.01M

10.88%-24.49M

-94.85%-35.09M

1,068.98%203.4M

-84.39%-93.79M

-32.92%-27.3M

-95.25%-27.48M

-127.67%-18.01M

Net income from continuing operations

452.05%23.5M

92.93%-6.69M

61.25%-9.54M

241.07%35.46M

-11.86%-25.93M

69.20%-6.67M

-84.95%-94.62M

-33.51%-24.63M

-74.20%-25.14M

-134.11%-23.18M

Depreciation and amortization

72.64%934K

49.92%2.84M

39.92%736K

61.63%834K

57.67%730K

38.72%541K

69.65%1.9M

44.51%526K

70.86%516K

83.73%463K

Change In working capital

-124.95%-51.65M

1,326.85%136.32M

149.39%2.95M

-1,025.92%-62.33M

-652.24%-11.32M

12,676.79%207.01M

-224.79%-11.11M

-55.82%-5.98M

-716.52%-5.54M

45.08%2.05M

-Change in receivables

-1,037.62%-71.64M

---5.88M

---853K

---1.28M

--2.55M

---6.3M

--0

-Change in prepaid assets

-38.23%2.68M

161.49%8.62M

725.17%12.52M

-55.36%-14.78M

881.03%6.55M

359.82%4.34M

-108.26%-14.02M

68.14%-2M

-1,332.53%-9.51M

-398.22%-838K

-Change in payables and accrued expense

-129.00%-1.35M

-28.63%5.03M

3,240.64%8.39M

-248.21%-5.92M

-191.39%-2.07M

767.48%4.64M

117.09%7.05M

-68.55%251K

86.34%4M

109.43%2.27M

-Change in other current assets

148.29%2.56M

-87.14%426K

146.70%1.03M

-6.23%1.82M

11.97%2.87M

-619.71%-5.3M

1,100.91%3.31M

-239.07%-2.21M

200.31%1.94M

28,588.89%2.56M

-Change in other current liabilities

7.79%-1.8M

-59.20%-11.86M

141.76%841K

-101.63%-3.96M

-249.79%-6.79M

-27.37%-1.95M

---7.45M

---2.01M

---1.96M

---1.94M

-Change in other working capital

-91.54%17.9M

--139.98M

---18.97M

---38.21M

---14.43M

--211.58M

----

Cash from discontinued investing activities

Operating cash flow

-112.55%-25.52M

249.07%139.8M

85.30%-4.01M

10.88%-24.49M

-94.85%-35.09M

1,068.98%203.4M

-84.39%-93.79M

-32.92%-27.3M

-95.25%-27.48M

-127.67%-18.01M

Investing cash flow

Cash flow from continuing investing activities

164.65%26.15M

6.90%-138.4M

1.34%19.04M

63.12%-3.74M

-567.52%-113.26M

77.72%-40.44M

-3,145.63%-148.65M

1,521.48%18.79M

-1,157.32%-10.13M

1,668.98%24.23M

Net PPE purchase and sale

49.76%-838K

-94.46%-5.61M

-37.85%-976K

-78.77%-1.45M

-96.39%-1.52M

-180.81%-1.67M

36.97%-2.89M

46.44%-708K

-0.50%-810K

49.81%-775K

Net investment purchase and sale

169.59%26.99M

8.91%-132.78M

2.66%20.02M

75.45%-2.29M

-546.94%-111.74M

78.57%-38.78M

---145.76M

--19.5M

---9.32M

--25M

Cash from discontinued investing activities

Investing cash flow

164.65%26.15M

6.90%-138.4M

1.34%19.04M

63.12%-3.74M

-567.52%-113.26M

77.72%-40.44M

-3,145.63%-148.65M

1,521.48%18.79M

-1,157.32%-10.13M

1,668.98%24.23M

Financing cash flow

Cash flow from continuing financing activities

-98.95%206K

4,291.86%21.04M

92.74%690K

513.33%368K

3,927.27%443K

38,972.00%19.54M

-99.84%479K

-99.81%358K

-43.40%60K

-94.88%11K

Net common stock issuance

--0

--19.41M

--0

--19.41M

--0

Proceeds from stock option exercised by employees

59.69%206K

240.29%1.63M

92.74%690K

513.33%368K

3,927.27%443K

158.00%129K

-48.99%479K

459.38%358K

-43.40%60K

-98.26%11K

Cash from discontinued financing activities

Financing cash flow

-98.95%206K

4,291.86%21.04M

92.74%690K

513.33%368K

3,927.27%443K

38,972.00%19.54M

-99.84%479K

-99.81%358K

-43.40%60K

-94.88%11K

Net cash flow

Beginning cash position

45.71%71.55M

-83.13%49.11M

-2.50%55.83M

-11.73%83.69M

161.43%231.6M

-83.13%49.11M

645.46%291.06M

-53.13%57.26M

-30.76%94.82M

-39.40%88.59M

Current changes in cash

-99.54%834K

109.28%22.45M

292.79%15.72M

25.81%-27.86M

-2,475.22%-147.91M

190.13%182.49M

-196.01%-241.96M

-104.83%-8.15M

-154.19%-37.56M

167.40%6.23M

End cash Position

-68.74%72.39M

45.71%71.55M

-2.50%55.83M

-11.73%83.69M

161.43%231.6M

-83.13%49.11M

-53.13%57.26M

-30.76%94.82M

Free cash flow

-113.07%-26.36M

238.81%134.19M

82.19%-4.99M

8.31%-25.94M

-94.92%-36.61M

1,034.59%201.73M

-74.37%-96.67M

-28.13%-28.01M

-90.12%-28.29M

-98.69%-18.78M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-112.55%-25.52M	249.07%139.8M	85.30%-4.01M	10.88%-24.49M	-94.85%-35.09M	1,068.98%203.4M	-84.39%-93.79M	-32.92%-27.3M	-95.25%-27.48M	-127.67%-18.01M
Net income from continuing operations	452.05%23.5M	92.93%-6.69M	61.25%-9.54M	241.07%35.46M	-11.86%-25.93M	69.20%-6.67M	-84.95%-94.62M	-33.51%-24.63M	-74.20%-25.14M	-134.11%-23.18M
Depreciation and amortization	72.64%934K	49.92%2.84M	39.92%736K	61.63%834K	57.67%730K	38.72%541K	69.65%1.9M	44.51%526K	70.86%516K	83.73%463K
Change In working capital	-124.95%-51.65M	1,326.85%136.32M	149.39%2.95M	-1,025.92%-62.33M	-652.24%-11.32M	12,676.79%207.01M	-224.79%-11.11M	-55.82%-5.98M	-716.52%-5.54M	45.08%2.05M
-Change in receivables	-1,037.62%-71.64M	---5.88M	---853K	---1.28M	--2.55M	---6.3M	--0	--0	--0	--0
-Change in prepaid assets	-38.23%2.68M	161.49%8.62M	725.17%12.52M	-55.36%-14.78M	881.03%6.55M	359.82%4.34M	-108.26%-14.02M	68.14%-2M	-1,332.53%-9.51M	-398.22%-838K
-Change in payables and accrued expense	-129.00%-1.35M	-28.63%5.03M	3,240.64%8.39M	-248.21%-5.92M	-191.39%-2.07M	767.48%4.64M	117.09%7.05M	-68.55%251K	86.34%4M	109.43%2.27M
-Change in other current assets	148.29%2.56M	-87.14%426K	146.70%1.03M	-6.23%1.82M	11.97%2.87M	-619.71%-5.3M	1,100.91%3.31M	-239.07%-2.21M	200.31%1.94M	28,588.89%2.56M
-Change in other current liabilities	7.79%-1.8M	-59.20%-11.86M	141.76%841K	-101.63%-3.96M	-249.79%-6.79M	-27.37%-1.95M	---7.45M	---2.01M	---1.96M	---1.94M
-Change in other working capital	-91.54%17.9M	--139.98M	---18.97M	---38.21M	---14.43M	--211.58M	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-112.55%-25.52M	249.07%139.8M	85.30%-4.01M	10.88%-24.49M	-94.85%-35.09M	1,068.98%203.4M	-84.39%-93.79M	-32.92%-27.3M	-95.25%-27.48M	-127.67%-18.01M
Investing cash flow
Cash flow from continuing investing activities	164.65%26.15M	6.90%-138.4M	1.34%19.04M	63.12%-3.74M	-567.52%-113.26M	77.72%-40.44M	-3,145.63%-148.65M	1,521.48%18.79M	-1,157.32%-10.13M	1,668.98%24.23M
Net PPE purchase and sale	49.76%-838K	-94.46%-5.61M	-37.85%-976K	-78.77%-1.45M	-96.39%-1.52M	-180.81%-1.67M	36.97%-2.89M	46.44%-708K	-0.50%-810K	49.81%-775K
Net investment purchase and sale	169.59%26.99M	8.91%-132.78M	2.66%20.02M	75.45%-2.29M	-546.94%-111.74M	78.57%-38.78M	---145.76M	--19.5M	---9.32M	--25M
Cash from discontinued investing activities
Investing cash flow	164.65%26.15M	6.90%-138.4M	1.34%19.04M	63.12%-3.74M	-567.52%-113.26M	77.72%-40.44M	-3,145.63%-148.65M	1,521.48%18.79M	-1,157.32%-10.13M	1,668.98%24.23M
Financing cash flow
Cash flow from continuing financing activities	-98.95%206K	4,291.86%21.04M	92.74%690K	513.33%368K	3,927.27%443K	38,972.00%19.54M	-99.84%479K	-99.81%358K	-43.40%60K	-94.88%11K
Net common stock issuance	--0	--19.41M	--0	--0	--0	--19.41M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	59.69%206K	240.29%1.63M	92.74%690K	513.33%368K	3,927.27%443K	158.00%129K	-48.99%479K	459.38%358K	-43.40%60K	-98.26%11K
Cash from discontinued financing activities
Financing cash flow	-98.95%206K	4,291.86%21.04M	92.74%690K	513.33%368K	3,927.27%443K	38,972.00%19.54M	-99.84%479K	-99.81%358K	-43.40%60K	-94.88%11K
Net cash flow
Beginning cash position	45.71%71.55M	-83.13%49.11M	-2.50%55.83M	-11.73%83.69M	161.43%231.6M	-83.13%49.11M	645.46%291.06M	-53.13%57.26M	-30.76%94.82M	-39.40%88.59M
Current changes in cash	-99.54%834K	109.28%22.45M	292.79%15.72M	25.81%-27.86M	-2,475.22%-147.91M	190.13%182.49M	-196.01%-241.96M	-104.83%-8.15M	-154.19%-37.56M	167.40%6.23M
End cash Position	-68.74%72.39M	45.71%71.55M	45.71%71.55M	-2.50%55.83M	-11.73%83.69M	161.43%231.6M	-83.13%49.11M	-83.13%49.11M	-53.13%57.26M	-30.76%94.82M
Free cash flow	-113.07%-26.36M	238.81%134.19M	82.19%-4.99M	8.31%-25.94M	-94.92%-36.61M	1,034.59%201.73M	-74.37%-96.67M	-28.13%-28.01M	-90.12%-28.29M	-98.69%-18.78M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall